| 16 June 2021 | |
| | |
INSPIRATION HEALTHCARE GROUP PLC
("IHG" or the "Company")
PDMR Dealing
The Company has been notified that on 9 June 2021, Toby Foster, the Managing Director of the Company's wholly owned subsidiary, Inspiration Healthcare Limited and a person discharging managerial responsibility ("PDMR") in the Company, made a transfer for nil consideration of 500,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares") to his spouse, Nia Foster, a person closely associated ("PCA") with Toby Foster (the "Transfer").
Following the Transfer, Mr Foster will directly hold 3,415,283 Ordinary Shares, with no change to his total beneficial holding, including those held by his wife as a PCA, of 3,915,283 Ordinary Shares.
This announcement, including the notification below, is made in accordance with the requirements of the EU Market Abuse Regulation.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||
| a. | Name | Toby Foster | ||||||
| 2 | Reason for notification | | ||||||
| a. | Position/Status | Managing Director of Inspiration Healthcare Limited | ||||||
| b. | Initial notification/ Amendment | Initial Notification | ||||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
| a. | Name | INSPIRATION HEALTHCARE GROUP PLC
| ||||||
| b. | LEI | 213800GKFT3ENAPMDL15 | ||||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
| a. | Description of the financial instrument, type of instrument | Ordinary Shares of 10p each
ISIN: GB00BXDZL105 | ||||||
| b. | Nature of the transaction | Transfer of Ordinary Shares to spouse | ||||||
| c. | Price(s) and volume(s) | | | | | | ||
| | Price(s) | Volume(s) | | |||||
| Nil consideration | 500,000 | | ||||||
|
| ||||||||
| d. | Aggregated information - Aggregated Volume - Price
| N/A | ||||||
| e. | Date of the transaction | 9 June 2021 | ||||||
| f. | Place of the transaction | XLON (AIM) | ||||||
Enquiries:
| Inspiration Healthcare Group plc | Tel: 01455 840 555
|
| Cenkos Securities plc - Nominated Adviser & Broker | Tel: 0207 397 8900
|
| Cadogan PR | Tel: 07771 713 608
|
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.
Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally, the Company has its own range of products for maintaining normothermia pre- during and post-surgery.
With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.
In the UK and Ireland, the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.
Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
